Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Invex Therapeutics.
RELATED STOCKHEAD STORIES
Health & Biotech
ASX Health Stocks: Big announcements as Invex and Antisense jump over 20pc this morning
News
Top 10 at 10: Copper hunter Cobre has gained 660% in just 3 weeks
Health & Biotech
Here are the Top 10 crucial trials coming up for ASX biotechs in 2022
Health & Biotech
ASX Health Stocks: UK grants Invex approval to start Phase 3 trial, share price surges 11pc
News
ASX Small Cap Lunch Wrap: Who’s jumping from the frying pan into the fire today?
Health & Biotech
ASX Health: Invex gets ready for Phase 3, Medlab gets US patent. Both jump 13pc this morning
News
ASX Small Cap Lunch Wrap: Who’s outperforming Warren Buffett today?
Health & Biotech
ASX Health Stocks: Invex jumps 14pc after deal in Korea, Noxopharm gets US Patent nod
Escrow Watch
Escrow Watch: These ASX companies are releasing shares in escrow this month
Health & Biotech
The surge and plunge in ASX biotech shows what the FDA giveth, the FDA taketh away
Health & Biotech
Megan Baldwin just joined the board of this ASX biotech stock
Health & Biotech
Chimeric IPO: What ASX stockspert Bhavdip143 likes so much about the $35m CAR T play
News
Rise and Shine: What you need to know before the ASX opens
News
Rise and Shine: What you need to know before the ASX opens
News
Small caps were still raising money in May; health beat resources again
News
Rise and Shine: What you need to know before the ASX opens
News
